Abstract
Inflammatory bowel disease, a dysregulated host‐microbiota interaction: Are probiotics a new therapeutic option?
Full Text
Sign-in/Register to access full text options
Published version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have